Odd Swarting

Senior Counsel | Advokat

Contact
email hidden; JavaScript is required +46 70 644 12 13
Odd Swarting

Advokat Odd Swarting AB in cooperation with Cirio.

Odd Swarting is a senior counsel and primarily advises clients in the life science, healthcare/pharmaceutical, medical device and forestry industries. He specializes above all in regulatory matters for pharmaceuticals and life science, ranging from market access (pricing and subsidies) to close collaboration with health care professionals and marketing departments. His practice largely involves commercial contracts, research and development projects and issues pertaining to the public sector. Odd also counsels clients during financial crises and on administering liquidations and restructurings.

Odd has 25 years' experience in providing qualified legal advice and has been ranked for many years as a leading Swedish lawyer by many institutes. He has previously been a Partner at Calissendorf Swarting, Setterwalls and Lindahl.

Odd has written numerous legal articles on life science law that have been published in The Life Sciences Law Review, Globe Law and Business, and Getting the Deal Through, Life Sciences.

Odd Swarting is a senior counsel at Cirio within the Biological practice, where he primarily advises clients in the life science, healthcare/pharmaceutical, medical device and forestry industries. He specializes above all in regulatory matters for pharmaceuticals and life science, ranging from market access (pricing and subsidies) to close collaboration with health care professionals and marketing departments. His practice largely involves commercial contracts, research and development projects and issues pertaining to the public sector. Odd also counsels clients during financial crises and on administering liquidations and restructurings.

Odd has 25 years' experience in providing qualified legal advice and has been ranked for many years as a leading Swedish lawyer by many institutes. He has previously been a Partner at Calissendorf Swarting, Setterwalls and Lindahl.

Odd has written numerous legal articles on life science law that have been published in The Life Sciences Law Review, Globe Law and Business, and Getting the Deal Through, Life Sciences.

  • Rankings

    Odd Swarting has "extensive experience and a good market reputation"
    - Legal 500

    Sources say he "excels in large cases thanks to his vast experience"
    - Chambers

  • CV
    2020
    Cirio
    2015-2019
    Calissendorff Swarting, partner
    2003-2015
    Setterwalls Advokatbyrå, partner
    1988-2002
    Advokatfirman Lindahl, partner
    1985-1988
    Åbjörnsson & Wallander Advokatbyrå, associate
    1983-1985
    District Court of Handen, junior judgeship
    Languages:

    Swedish and English

  • Education
    University of Stockholm, Master of Law (LL.M.), and financial studies
  • Membership
    1988
    Swedish Bar Association
    International Bar Association
    2017-
    Chairman and Deputy Chairman of UNICEF Sweden (2007-) and chairman of the election committee
    Chairman of REKON (The Restructuring and Bankruptcy Trustees’ Organization in Sweden) (2003-2015)
    1997- and 2006-
    The Swedish Sports Confederation’s Legal Committee and Vice chair Swedish Football Association License Committee
    2015-2019
    Chairman SALK
    2012-2014
    AIK Ice hockey Club
    Different officers positions at the International Bar Association
    2009-2010
    Expert in the Official Report of the Swedish Government on united insolvency laws, on purchases of movables and on registered pledges (2014-2015) and on entrepreneurs (2015-2016)
    Board member of inter alia G Förvaltning AB (administering the funds of Göran Gustafsson Foundations), Hotel Diplomat AB, VlVBio AB, Johanneshöjdens Kapitalförvaltning AB, and secretary of the board of Recipharm AB (publ)
  • Publications



    • "Debt Restructuring” European Lawyer Reference 2015
    • "Coveted action plan for the Life Science Industry" Life Sciences Report November 2014
    • "Life Sciences", Getting the Deal trough, Swedish chapter
    • “Life Sciences Law Review”, Swedish chapter, The Law review
    • ”Pricing and Reimbursement”, Global Legal Insights
    • "Restructuring and Insolvency", Getting the Deal trough, Swedish chapter
    • "How to maintain the value of a licence agreement on the insolvency of the other party" Life Sciences Report November 2013
    • "Stem cell research from a legal perspective" Life Scineces Report November 2012
    • "Signing a deal with a CRO"- Nordic Life Science Review 2012
    • "Global Reference Guide Biotech & Pharmaceuticals", Swedish Chapter, 2010
    • “Life sciences in Sweden – An overview of trends and developments“, Global Reference Guide Biotech & Pharmaceuticals, Financier Worldwide, 2010